Approval · Notice of Compliance 6022 · 1997
ONE-ALPHA: Notice of Compliance 6022
Issued April 7, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6022
- Date
- April 7, 1997
- Company
- Leo Laboratories Ltd.Aylesbury, Buckinghamshire, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: also used for patients with renal failure who do not yet require dialysis
- Therapeutic class
- Vitamin d analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONE-ALPHA | Not yet assigned | — |
Medicinal ingredients
- ALFACALCIDOL 0.25 MCG per CAP
- ALFACALCIDOL 1 MCG per CAP
- ALFACALCIDOL 0.2 MCG per ML